Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production-Reference-Cited by-同舟云学术

Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production

Published:2001-03 Issue:4 Volume:120 Page:867-873
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Wight Nicholas J.,Gottesdiener Keith,Garlick Nigel M.,Atherton Clare T.,Novak Sue,Gertz Barry J.,Calder Nicole A.,Cote J.,Wong P.,Dallob Amy,Hawkey Chris J.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study;Singh;Arch Intern Med,1996

2. Non-steroidal anti-inflammatory drugs and peptic ulcers;Hawkey;BMJ,1990

3. Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use;Tramer;Pain,2000

4. Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use;Fries;Gastroenterology,1989

5. Nonsteroidal anti-inflammatory drug–associated gastropathy: incidence and risk factor models;Fries;Am J Med,1991

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Costus afer (Costaceae, Zingiberales) leaf extract ameliorates naproxen-induced gastric ulcer in rats;Tropical Journal of Pharmaceutical Research;2021-03-15

2. Increased Gastric Mucus Secretion Alleviates Non-Steroidal Anti-Inflammatory Drug-Induced Abdominal Pain;The Tohoku Journal of Experimental Medicine;2013

3. Gastrointestinal Tract;Comparative Pathophysiology and Toxicology of Cyclooxygenases;2012-08-20

4. Endoscopic evaluation of the gastro-duodenal tolerance of short-term analgesic treatment with 25 mg diclofenac-K liquid capsules;Alimentary Pharmacology & Therapeutics;2012-02-28

5. Berberine ameliorates COX-2 expression in rat small intestinal mucosa partially through PPARγ pathway during acute endotoxemia;International Immunopharmacology;2012-01